緊急の 警告 over 不足s of life-saving 麻薬s: Damning 報告（する）／憶測 明らかにする／漏らすs 患者s are at 危険 because of Britain's 'broken' 薬／医学 供給（する） chain... so are 在庫／株s of YOUR meds running low?

• e-mail

Sick Britons are 直面するing alarming 麻薬 不足s and 存在 made to wait longer for new 薬／医学s than our European 隣人s, a damning 報告（する）／憶測 明らかにする／漏らすs.

The 政府 has been 勧めるd to carry out a review of the UK's 'broken' 薬／医学 供給（する） chain as costs 急に上がる and 患者s are left in 苦痛.

専門家s 述べるd 不足s of the likes of painkillers, 抗生物質s and epilepsy 麻薬s as a 'shocking 開発' that is also piling 圧力 GPs and pharmacists.

The 研究 by the Nuffield 信用 think 戦車／タンク 最高潮の場面s 'underlying fragilities' in the 全世界の and UK 供給（する） chain に引き続いて pandemic lockdowns and Brexit.

Its 分析 of freedom of （警察などへの）密告，告訴（状） requests and public data 明らかにする／漏らすs the number of notifications from 麻薬 companies 警告 of 差し迫った 不足s has more than 二塁打d from 648 in 2020 to 1,634 in 2023.

The Department of Health and Social Care had to 供給する pharmacists with an 付加 £220million in the year to September to subsidise 購入（する）s where there were no 麻薬s left at the usual NHS price.

事前の to 2016 there were rarely more than 20 いわゆる 'price 譲歩s' per month but they 頂点（に達する）d at 199 in late 2022 and have remained high ever since.

一方／合間, Britain has been slower to 認可する 麻薬s than the EU, 分析 示唆するs.

Between 2022 and 2023, only four 麻薬s authorised by the European （売買）手数料，委託（する）／委員会／権限 (欧州共同体) had been 認可するd faster in Britain.

However, 56 were 認可するd after the 欧州共同体 and eight had not been 認可するd at all as of March this year.

The '未来 for health after Brexit' 報告（する）／憶測 said while problems in the UK were not 原因（となる）d by Brexit, leaving the European Union (EU) has 悪化させるd them.

This is 予定 to the 落ちる in the value of 英貨の／純銀の and the UK 存在 除去するd from EU 供給（する） chains.

Lead author 示す Dayan, from the Nuffield 信用, said: 'We know many of the problems are 全世界の and relate to 壊れやすい chains of 輸入するs from Asia, squeezed by Covid shutdowns, インフレーション and 全世界の 不安定.

'公式の／役人s in the UK have put in place a much more sophisticated system to 監視する and 答える／応じる, and used extra 支払い（額）s to try to keep 製品s flowing.

'But 出口ing the EU has left the UK with several 付加 problems ? 製品s no longer flow as 滑らかに across the 国境s with the EU, and in the long 称する，呼ぶ／期間／用語 our struggles to 認可する as many 薬／医学s might mean we have より小数の 代案／選択肢s 利用できる.'

The 報告（する）／憶測 identifies other unique 問題／発行するs for the UK market, 含むing a change in 需要・要求する to the 薬／医学s 定める／命ずるd by doctors.

One example used was prescriptions for hormone 交替／補充 therapy (HRT) for menopausal women, which 増加するd by 40 per cent in 2021/22.

Mr Dayan 追加するd: 'The rise in 不足s of 決定的な 薬／医学s from rare to commonplace has been a shocking 開発 that few would have 推定する／予想するd a １０年間 ago.

'More and more 患者s across the UK are experiencing a pharmacist telling them that their 医薬 is not 利用できる, it may not be 利用できる soon, and it may not be 利用できる anywhere nearby. This is also creating a 広大な／多数の／重要な 取引，協定 of extra work for both GPs and pharmacists.'

The 政府 has been 勧めるd to carry out a review of the UK's 'broken' 薬／医学 供給（する） chain as costs 急に上がる and pati ents are left in 苦痛

Louise Ansari, 長，指導者 (n)役員／(a)執行力のある at Healthwatch England, 警告するd that '不足s of 決定的な 医薬 can have a detrimental 衝撃 on people's 条件, and their lives'.

'We are calling on the 政府 to carry out a review of the 薬／医学 供給（する） chain to 確実にする 薬／医学 safety and resilience,' she 追加するd.

Dr Leyla Hannbeck, 長，指導者 (n)役員／(a)執行力のある of the 協会 of 独立した・無所属 多重の Pharmacies, said: 'The 薬／医学s 供給（する） chain is broken at every level and unless the Department of Health reviews its 過程s and 手続きs, we will never 達成する the 安定 that will 保証（人） 患者s their prescription when they need it.

'Pharmacists spend hours every day trying to source 薬／医学s for 患者s.'

Paul Rees, 長，指導者 (n)役員／(a)執行力のある of the 国家の Pharmacy 協会, said 薬／医学 不足s 'have become commonplace', which is '全く 容認できない'.

'供給（する） 不足s are a real and 現在の danger to those 患者s who rely on life-saving 薬／医学s for their wellbeing,' he 追加するd.

'確実にするing an 適する 供給（する） of 薬／医学s is surely a basic 機能（する）／行事 of any modern health system.'

A Department of Health and Social Care spokesperson said: 'There are around 14,000 licensed 薬／医学s and the 圧倒的な 大多数 are in good 供給（する）.

'薬／医学 供給（する） 問題／発行するs do not only 影響する／感情 the UK, and we have a 範囲 of 井戸／弁護士席-設立するd 過程s and 道具s to manage them when they do occur.

'That's why most 供給（する） 問題／発行するs have been 速く managed with 極小の disruption to 患者s.

'Our 優先 is to 確実にする 患者s continue to get the 治療s they need, which is why we work with 産業, the NHS, and others to 確実にする 患者s continue to have acc ess to an 代案／選択肢 治療 until their usual 製品 is 支援する in 在庫／株.'